Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. My colleague Allison DeAngelis has been working for months on our annual VC rankings report. Read on for what she found.
Third Rock tops STAT’s annual VC ranking
Among biotech venture capital firms, Third Rock Venture has generated the best returns on its investments in 2024 and 2025, according to STAT’s annual VC rankings report.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
